The digital health fundraising market seems to be truly normalizing following the highs and lows of the pandemic, according to market research. During the first half of this year, U.S. digital health startups raked in $5.7 billion across 266 deals.
Payer incentives are often not aligned with implementing interventions that will benefit patient health the most in the long term. Enter Nobil, which aims to create a healthcare futures market that invests in interventions with the greatest impact over time.
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
In the new year, payers with an abundance of capital resulting from deferred care amid the pandemic will look to make investments in technology and ramp up acquisition activity in the primary care arena, a PwC expert predicts.
Rock Health's latest report found that in the first quarter of 2019, $986 million was invested across digital health deals, which is a little more than half the amount that was raised in Q1 2018.
A digital health funding report from StartUp Health notes that there have been 414 deals thus far in 2018, up from 344 deals at the same point in 2017. Additionally, it highlights how patient empowerment is the most funded function (or a company's main activity) so far this year.
Only one in 500 new businesses in the United States will reach at least $100 million in revenue, and only one in 17,000 will see $500 million in revenue.
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.